APA

Ahmed O. A., Kaisar H. H., Badawi R., Hawash N., Samir H., Shabana S. S., Fouad M. H. A., Rizk F. H., Khodeir S. A. & Abd-Elsalam S. (2018). Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. : Infection and drug resistance.

Chicago

Ahmed Ossama A, Kaisar Hany H, Badawi Rehab, Hawash Nehad, Samir Hossam, Shabana Sherif St, Fouad Mohamed Hassan A, Rizk Fatma H, Khodeir Samy A and Abd-Elsalam Sherief. 2018. Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. : Infection and drug resistance.

Harvard

Ahmed O. A., Kaisar H. H., Badawi R., Hawash N., Samir H., Shabana S. S., Fouad M. H. A., Rizk F. H., Khodeir S. A. and Abd-Elsalam S. (2018). Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. : Infection and drug resistance.

MLA

Ahmed Ossama A, Kaisar Hany H, Badawi Rehab, Hawash Nehad, Samir Hossam, Shabana Sherif St, Fouad Mohamed Hassan A, Rizk Fatma H, Khodeir Samy A and Abd-Elsalam Sherief. Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. : Infection and drug resistance. 2018.